- Home
- GRBK vs RGC Comparison
GRBK vs RGC Comparison
Compare GRBK & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRBK | RGC |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Hong Kong |
| Employees | 620 | N/A |
| Industry | Homebuilding | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GRBK | RGC |
|---|---|---|
| Price | $73.14 | $5.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $71.00 | N/A |
| AVG Volume (30 Days) | ★ 230.4K | 159.4K |
| Earning Date | 04-29-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.09 | N/A |
| Revenue | ★ $2,098,471,000.00 | N/A |
| Revenue This Year | $0.07 | N/A |
| Revenue Next Year | $10.33 | N/A |
| P/E Ratio | $23.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $60.44 | $4.51 |
| 52 Week High | $83.18 | $69.00 |
Technical Indicators
Market Signals| Indicator | GRBK | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 56.33 | 41.66 |
| Support Level | $69.06 | $4.91 |
| Resistance Level | $74.01 | $6.22 |
| Average True Range (ATR) | 1.52 | 0.36 |
| MACD | 0.38 | 0.19 |
| Stochastic Oscillator | 84.17 | 48.16 |
Price Performance
Historical ComparisonAbout GRBK Green Brick Partners Inc.
Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment, which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgages and title.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.